Boston Scientific Current Ratio 2006-2018 | BSX

Current and historical current ratio for Boston Scientific (BSX) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Boston Scientific current ratio for the three months ending December 31, 2018 was 0.76.
Boston Scientific Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $4.00B $5.26B 0.76
2018-09-30 $3.97B $5.08B 0.78
2018-06-30 $3.93B $4.75B 0.83
2018-03-31 $4.08B $4.99B 0.82
2017-12-31 $3.82B $5.65B 0.68
2017-09-30 $3.48B $4.83B 0.72
2017-06-30 $3.22B $4.30B 0.75
2017-03-31 $3.03B $3.49B 0.87
2016-12-31 $3.24B $3.59B 0.90
2016-09-30 $3.18B $3.02B 1.06
2016-06-30 $3.33B $3.18B 1.05
2016-03-31 $3.16B $2.61B 1.21
2015-12-31 $3.47B $2.43B 1.43
2015-09-30 $3.46B $2.24B 1.55
2015-06-30 $3.77B $1.94B 1.95
2015-03-31 $3.19B $2.46B 1.30
2014-12-31 $3.61B $2.85B 1.27
2014-09-30 $3.18B $1.82B 1.75
2014-06-30 $3.21B $1.77B 1.81
2014-03-31 $2.94B $1.72B 1.71
2013-12-31 $3.01B $1.82B 1.65
2013-09-30 $3.53B $1.90B 1.85
2013-06-30 $3.50B $2.48B 1.41
2013-03-31 $3.10B $1.64B 1.90
2012-12-31 $3.02B $1.77B 1.71
2012-09-30 $3.17B $1.82B 1.75
2012-06-30 $3.11B $1.79B 1.73
2012-03-31 $3.09B $1.67B 1.85
2011-12-31 $3.11B $1.81B 1.72
2011-09-30 $3.21B $1.89B 1.70
2011-06-30 $3.15B $1.89B 1.66
2011-03-31 $3.57B $2.04B 1.75
2010-12-31 $3.62B $2.61B 1.39
2010-09-30 $3.56B $2.96B 1.20
2010-06-30 $3.99B $3.72B 1.07
2010-03-31 $3.75B $2.91B 1.29
2009-12-31 $4.60B $3.02B 1.52
2009-09-30 $4.96B $3.18B 1.56
2009-06-30 $4.80B $2.75B 1.74
2009-03-31 $4.57B $2.43B 1.88
2008-12-31 $5.45B $3.23B 1.69
2008-09-30 $5.29B $3.54B 1.49
2008-06-30 $5.17B $3.04B 1.70
2008-03-31 $5.24B $3.39B 1.55
2007-12-31 $5.94B $3.25B 1.83
2007-09-30 $4.69B $3.38B 1.39
2007-06-30 $4.94B $2.97B 1.66
2007-03-31 $4.58B $2.37B 1.93
2006-12-31 $6.03B $2.63B 2.29
2006-09-30 $4.75B $2.45B 1.94
2006-06-30 $4.41B $2.17B 2.03
2006-03-31 $2.87B $2.04B 1.41
2005-12-31 $2.63B $1.48B 1.78
2005-09-30 $2.76B $1.14B 2.42
2005-06-30 $2.72B $1.76B 1.55
2005-03-31 $2.76B $1.78B 1.55
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $48.570B $9.823B
Boston Scientific Corporation transforms lives through innovative medical solutions that improve the health of patients around the world. As a global medical technology leader they advance science for life by providing a broad range of high performance solutions that address unmet patient needs and reduce the cost of healthcare.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $130.875B 25.52
Medtronic (MDT) Ireland $112.858B 16.50
Stryker (SYK) United States $67.965B 24.92
Baxter (BAX) United States $38.462B 24.67
Zimmer Biomet Holdings (ZBH) United States $24.795B 15.86
Canopy Growth (CGC) Canada $16.605B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $16.541B 0.00
ResMed (RMD) United States $14.331B 27.18
Aurora Cannabis (ACB) Canada $9.351B 65.93
Bio-Rad Laboratories (BIO) United States $8.746B 50.17
Perrigo (PRGO) Ireland $6.654B 10.79
Hill-Rom Holdings (HRC) United States $6.265B 19.38
Insulet (PODD) United States $4.918B 1648.60
GW Pharmaceuticals (GWPH) United Kingdom $4.886B 0.00
ICU Medical (ICUI) United States $4.648B 28.79
Haemonetics (HAE) United States $4.248B 37.69
Hutchison China MediTech (HCM) China $4.058B 0.00
Agios Pharmaceuticals (AGIO) United States $3.323B 0.00
Neogen (NEOG) United States $2.935B 47.73
NuVasive (NUVA) United States $2.870B 24.93
Quidel (QDEL) United States $2.395B 21.43
National Vision Holdings (EYE) United States $2.233B 43.92
Aphria (APHA) $1.970B 0.00
HEXO (HEXO) $1.493B 0.00
Phibro Animal Health (PAHC) United States $1.350B 19.40
Cardiovascular Systems (CSII) United States $1.210B 868.75
VAREX IMAGING (VREX) United States $1.209B 23.67
AtriCure (ATRC) United States $1.055B 0.00
Lantheus Holdings (LNTH) United States $0.930B 25.13
Omeros (OMER) United States $0.916B 0.00
PetIQ (PETQ) United States $0.851B 24.35
Cerus (CERS) United States $0.808B 0.00
MacroGenics (MGNX) United States $0.796B 0.00
NanoString Technologies (NSTG) United States $0.744B 0.00
TG Therapeutics (TGTX) United States $0.699B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.676B 23.00
Evolus (EOLS) United States $0.665B 0.00
OraSure Technologies (OSUR) United States $0.585B 25.46
Surmodics (SRDX) United States $0.569B 82.72
LeMaitre Vascular (LMAT) United States $0.539B 25.61
Meridian Bioscience (VIVO) United States $0.534B 15.90
Quanterix (QTRX) United States $0.492B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.330B 0.00
Insys Therapeutics (INSY) United States $0.322B 0.00
Utah Medical Products (UTMD) United States $0.321B 20.90
BioLife Solutions (BLFS) United States $0.303B 125.08
Vapotherm (VAPO) United States $0.281B 0.00
Rockwell Medical (RMTI) United States $0.263B 0.00
Cytosorbents (CTSO) United States $0.227B 0.00
Owens & Minor (OMI) United States $0.214B 2.93
Zynex (ZYXI) United States $0.170B 18.21
Chimerix (CMRX) United States $0.136B 0.00
Bovie Medical (APYX) United States $0.132B 0.00
Fonar (FONR) United States $0.123B 6.59
Chembio Diagnostics (CEMI) United States $0.120B 0.00
Surface Oncology (SURF) United States $0.111B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 20.42
InfuSystems Holdings (INFU) United States $0.088B 0.00
Neurotrope (NTRP) United States $0.078B 0.00
Trinity Biotech (TRIB) Ireland $0.069B 20.64
Oramed Pharmaceuticals (ORMP) United States $0.069B 0.00
GUARDION HEALTH (GHSI) United States $0.049B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Senestech (SNES) United States $0.036B 0.00
Valeritas Holdings (VLRX) United States $0.030B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.023B 0.00
Myomo (MYO) United States $0.021B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Akers Biosciences Inc (AKER) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.007B 13.00